Skip to main content

Cellectar Biosciences, Inc.

CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001279704

No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Cellectar Biosciences, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CLRB: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders3219−13
Shares5.21M103.4K−5.10M (−98.0%)
Value$1.63M$734.0K−$894.3K (−54.9%)

New holders (6)

Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CLRB in Q2 2025
InstitutionSharesValue% of portfolio
Riverview Capital Advisers, LLC10,500$74.7K0.02%
Tower Research Capital LLC (TRC)195$1.39K0.00%
Raymond James Financial Inc133$9460.00%
Jones Financial Companies LLLP3$240.00%
Danske Bank A/S2$140.00%
Citigroup Inc1$70.00%

Sold out (19)

Institutions that held Cellectar Biosciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of CLRB in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Squarepoint Ops LLC370,865$116.9K
Citadel Advisors LLC343,258$108.2K
Sequoia Financial Advisors, LLC203,260$64.1K
Baader Bank INC172,940$43.1K
State Street Corp128,114$40.4K
XTX Topco Ltd104,323$32.9K
Two Sigma Investments, LP83,099$26.2K
Northern Trust Corp77,988$24.6K
Rochester Wealth Strategies, LLC43,000$13.6K
ADAR1 Capital Management, LLC40,228$12.7K
Nordwand Advisors, LLC20,000$6.31K
JustInvest LLC17,587$5.54K
Commonwealth Equity Services, LLC12,051$4.00K
Oppenheimer & Co Inc12,500$3.94K
Goldman Sachs Group Inc10,807$3.41K
Commerce Bank10,000$3.15K
EverSource Wealth Advisors, LLC1,646$519
JPMorgan Chase & Co76$24
AllSquare Wealth Management LLC18$6